Treace Medical Concepts (TMCI) Accumulated Depreciation & Amortization (2020 - 2026)

Treace Medical Concepts has reported Accumulated Depreciation & Amortization for 7 years, with the latest figure at $23.9 million in Q1 2026.

• For the quarter ending Q1 2026, Accumulated Depreciation & Amortization rose 36.36% year-over-year to $23.9 million; the trailing twelve-month figure through Mar 2026 stood at $23.9 million (up 36.36% YoY), and the FY2025 full-year result was $23.9 million, up 55.96% from the prior year.
• Accumulated Depreciation & Amortization for Q1 2026 stood at $23.9 million, roughly flat from $23.9 million in the prior quarter.
• The five-year high for Accumulated Depreciation & Amortization was $23.9 million in Q1 2026, with the low at $2.9 million in Q1 2022.
• Historically, Accumulated Depreciation & Amortization has averaged $11.8 million across 5 years, with a median of $10.4 million in 2024.
• The largest YoY upside for Accumulated Depreciation & Amortization was 2418.8% in 2022 against a maximum downside of 26.85% in 2022.
• Treace Medical Concepts' Accumulated Depreciation & Amortization stood at $4.3 million in 2022, then jumped by 105.21% to $8.7 million in 2023, then surged by 74.95% to $15.3 million in 2024, then jumped by 55.96% to $23.9 million in 2025, then gained by 0.28% to $23.9 million in 2026.
• The last three Accumulated Depreciation & Amortization figures came in at $23.9 million (Q1 2026), $23.9 million (Q4 2025), and $21.8 million (Q3 2025), per Business Quant data.